Myalept (Aegerion Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Myalept drug offered from Aegerion Pharmaceuticals, Inc.. This Leptin Analog [EPC],Analogs/Derivatives [Chemical/Ingredient],Leptin [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aegerion Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: metreleptin
SUBSTANCE NAME: METRELEPTIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Leptin Analog [EPC],Analogs/Derivatives [Chemical/Ingredient],Leptin [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2015-03-05
END MARKETING DATE: 0000-00-00


Myalept HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMyalept from Aegerion Pharmaceuticals, Inc.
LABELER NAME: Aegerion Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 11.3(mg/2.2mL)
START MARKETING DATE: 2015-03-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76431-210_82a9c700-28e5-4d9b-80e7-c343ba5da1fc
PRODUCT NDC: 76431-210
APPLICATION NUMBER: BLA125390

Other METRELEPTIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aegerion Pharmaceuticals, Inc.Myalept